Updated analysis of SWOG 0023: A randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer. - Kelly,K.; Chansky,K.; Gaspar,L.E. (J Clin Oncol, 2007)